Hybrid simultaneous whole-body 2-[18F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results

被引:5
作者
Jamet, Bastien [1 ]
Carlier, Thomas [1 ,2 ]
Bailly, Clement [1 ,2 ]
Bodet-Milin, Caroline [1 ,2 ]
Monnet, Aurelien [4 ]
Frampas, Eric [5 ]
Touzeau, Cyrille [2 ,3 ]
Moreau, Philippe [2 ,3 ]
Kraeber-Bodere, Francoise [1 ,2 ]
机构
[1] Univ Hosp, Nucl Med Dept, 1 Pl Ricordeau, F-44093 Nantes, France
[2] Univ Angers, Nantes Univ, INSERM, CNRS,CRCI2NA, F-44000 Nantes, France
[3] Univ Hosp, Haematol Dept, Nantes, France
[4] Siemens, St Denis, France
[5] Univ Hosp, Radiol Dept, Nantes, France
关键词
Multiple myeloma; Positron emission tomography; Magnetic resonance imaging; Clinical decision-making; Diagnostic techniques; radioisotope; POSITRON-EMISSION-TOMOGRAPHY; FDG PET/CT; MRI; CRITERIA; LESIONS;
D O I
10.1007/s00330-023-09593-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesMixing diagnostic and prognostic data provided by whole-body MRI (WB-MRI) and 2-F-18-fluorodeoxyglucose (2-[F-18]FDG) positron emission tomography (2-[F-18]FDG-PET) from a single simultaneous imaging technique for newly diagnosed multiple myeloma (NDMM) initial workup seems attractive. However, to date, the published data are scarce and this possibility has not been fully explored. In this prospective study, we aimed to explore the diagnostic performance and added clinical value of WB-2-[F-18]FDG-PET/MRI imaging in NDMM.MethodsAll patients with confirmed NDMM at the Nantes University Hospital were prospectively enrolled in this study and underwent WB-2-[F-18]FDG-PET/MRI imaging on a 3-T Biograph mMR before receiving treatment. Before imaging, they were considered either as symptomatic or as smoldering MM (SMM). Diagnostic performance of global WB-2-[F-18]FDG-PET/MRI imaging, as well as PET and MRI separately for FL and diffuse BMI detection, was assessed and compared in each group. PET-based (maximal standardized uptake value, SUVmax) and MRI-based (mean apparent diffusion coefficient value, ADC(mean)) quantitative features were collected for FL/para-medullary disease (PMD)/bone marrow and were compared.ResultsA total of 52 patients were included in this study. PET and MRI were equally effective at detecting patients with FL (69% vs. 75%) and with diffuse BMI (62% for both) in the symptomatic MM group. WB-2-[F-18]FDG-PET/MRI imaging detected FL in 22% of patients with SMM (with a higher diagnostic performance for MRI), resulting in a significant impact on clinical management in this population. SUVmax and ADC(mean) quantitative features were weakly or not correlated.ConclusionsWB-2-[F-18]FDG-PET/MRI could represent the next-generation imaging modality for MM.
引用
收藏
页码:6438 / 6447
页数:10
相关论文
共 49 条
  • [31] 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis
    Machado Medeiros, Tassia
    Altmayer, Stephan
    Watte, Guilherme
    Zanon, Matheus
    Basso Dias, Adriano
    Henz Concatto, Natalia
    Hoefel Paes, Julia
    Mattiello, Rita
    de Souza Santos, Francisco
    Mohammed, Tan-Lucien
    Verma, Nupur
    Hochhegger, Bruno
    EUROPEAN RADIOLOGY, 2020, 30 (07) : 3641 - 3649
  • [32] 99mTc-sestamibi SPECT/CT and18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma
    Mosci, Camila
    Pericole, Fernando V.
    Oliveira, Gislaine B.
    Delamain, Marcia T.
    Takahashi, Maria E. S.
    Carvalheira, Jose Barreto C.
    Etchebehere, Elba C. S. C.
    Santos, Allan O.
    Miranda, Eliana C. M.
    Lima, Mariana C. L.
    Amorim, Barbara J.
    de Souza, Carmino A.
    Lorand-Metze, Irene
    Ramos, Celso D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (10) : 1081 - 1088
  • [33] Comparison of whole-body DW-MRI with 2-[18F]FDG PET for staging and treatment monitoring of children with Langerhans cell histiocytosis
    Baratto, Lucia
    Nyalakonda, Ramyashree
    Theruvath, Ashok J. J.
    Sarrami, Amir Hossein
    Hawk, Kristina Elizabeth
    Rashidi, Ali
    Shen, Sa
    States, Lisa
    Aboian, Mariam
    Jeng, Michael
    Daldrup-Link, Heike E. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (06) : 1689 - 1698
  • [34] Diagnostic performance of integrated whole-body 18F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with 18F-FDG PET or MRI alone
    Chen, Xuetao
    Yuan, Tingting
    Wei, Maomao
    Yu, Boqi
    Zhou, Nina
    Zhu, Hua
    Yang, Zhi
    Wang, Xuejuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Low-dose and standard-dose whole-body [18F]FDG-PET/CT imaging: implications for healthy controls and lung cancer patients
    Ferrara, Daria
    Sundar, Lalith Kumar Shiyam
    Chalampalakis, Zacharias
    Geist, Barbara Katharina
    Gompelmann, Daniela
    Gutschmayer, Sebastian
    Hacker, Marcus
    Kertesz, Hunor
    Kluge, Kilian
    Idzko, Marco
    Langsteger, Werner
    Yu, Josef
    Rausch, Ivo
    Beyer, Thomas
    FRONTIERS IN PHYSICS, 2024, 12
  • [36] Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma
    Sheng-Chieh Chan
    Chih-Hua Yeh
    Tzu-Chen Yen
    Shu-Hang Ng
    Joseph Tung-Chieh Chang
    Chien-Yu Lin
    Tsang Yen-Ming
    Kang-Hsing Fan
    Bing-Shen Huang
    Cheng-Lung Hsu
    Kai-Ping Chang
    Hung-Ming Wang
    Chun-Ta Liao
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1297 - 1308
  • [37] Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma
    Chan, Sheng-Chieh
    Yeh, Chih-Hua
    Yen, Tzu-Chen
    Ng, Shu-Hang
    Chang, Joseph Tung-Chieh
    Lin, Chien-Yu
    Yen-Ming, Tsang
    Fan, Kang-Hsing
    Huang, Bing-Shen
    Hsu, Cheng-Lung
    Chang, Kai-Ping
    Wang, Hung-Ming
    Liao, Chun-Ta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (08) : 1297 - 1308
  • [38] Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma
    Marchiori, Silvano
    Cousin, Francois
    Papadopoulos, Iraklis
    Bernard, Claire
    Thys, Marie
    De Prijck, Bernard
    Pirotte, Michelle
    Donneau, Anne-Francoise
    Hustinx, Roland
    Caers, Jo
    Withofs, Nadia
    EJNMMI RESEARCH, 2024, 14 (01):
  • [39] Bone marrow MRI versus 18F-FDG-PET/CT for detecting multiple myeloma lesions: diagnostic performance and clinical relevance
    Lecouvet, Frederic
    Boyadzhiev, Dimitar
    Collette, Laurence
    Berckmans, Maude
    Michoux, Nicolas
    Triqueneaux, Perrine
    Pasoglou, Vassiliki
    Jamar, Francois
    Vekemans, Marie-Christiane
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E35 - E36
  • [40] DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach
    Jamet, Bastien
    Necib, Hatem
    Carlier, Thomas
    Frampas, Eric
    Bazin, Juliette
    Desfontis, Paul-Henri
    Monnet, Aurelien
    Bodet-Milin, Caroline
    Moreau, Philippe
    Touzeau, Cyrille
    Kraeber-Bodere, Francoise
    CANCER IMAGING, 2024, 24 (01)